NPPA Fixes Retail Price Of 42 Formulations; Details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 42 formulations including those used to treat high Blood Pressure (BP), high cholesterol, gastroesophageal reflux disease, Peptic ulcer disease, type 2 diabetes and others.These include Sun Pharma Ltd's...
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 42 formulations including those used to treat high Blood Pressure (BP), high cholesterol, gastroesophageal reflux disease, Peptic ulcer disease, type 2 diabetes and others.
These include Sun Pharma Ltd's Fixed-Dose Combination (FDC) of Telmisartan, Cilnidipine and Metoprolol (ER) tablet, Paracetamol plus Phenylephrine plus Chlorpheniramine tablet manufactured by Alembic Pharma, Cadila Healthcare's FDC drug Telmisartan, Cilnidipine and Metoprolol (ER) tablet as well as Ajanta Pharma and Glenmark Pharma's extended-release fixed-dose combination drug Telmisartan plus Chlorthalidone plus Metoprolol.
In addition to this, the list also includes Pure and Cure Healthcare, Mankind pharma's Atorvastatin Table, Torrent's antibiotic drug combination Amoxycillin and Potassium Clavulanate Oral Suspension, East African (India) Overseas and Intas pharmaceutical's Iron Vitamin B12 and Folic Acid Syrup.
This comes in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 701(E) dated 10th March 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Telmisartan + Cilnidipine + Metoprolol (ER) tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Sun Pharma Laboratories Limited | 12.41 |
2. | Telmisartan + Cilnidipine + Metoprolol (ER) tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Sun Pharma Laboratories Limited | 10.16 |
3. | Paracetamol + Phenylephrine + Chlorpheniramine tablet | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 10mg Chlorpheniramine maleate IP 2mg | 1 Tablet | M/s Alembic Pharmaceuticals Limited | 3.82 |
4. | Telmisartan + Cilnidipine + Metoprolol (ER) tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd. | 10.16 |
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
5. | Telmisartan + Cilnidipine + Metoprolol (ER) tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd. | 12.41 |
6. | Telmisartan + Chlorthalidone + Metoprolol (Extended Release) tablet | Each film coated tablet contains:Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (Extended Release form) 25mg | 1 Tablet | M/s Ajanta Pharma Limited / M/s Glenmark Pharmaceuticals Ltd. | 11.76 |
7. | Telmisartan + Chlorthalidone + Metoprolol (Extended Release) tablet | Each film coated tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (Extended Release form) 50mg | 1 Tablet | M/s Ajanta Pharma Limited / M/s Glenmark Pharmaceuticals Ltd. | 13.97 |
8. | Telmisartan + Chlorthalidone + Metoprolol (Extended Release) tablet | Each film coated tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (Extended Release form) 50mg | 1 Tablet | M/s Ajanta Pharma Limited / M/s Glenmark Pharmaceuticals Ltd. | 10.81 |
9. | Telmisartan + Chlorthalidone + Metoprolol (Extended Release) tablet | Each film coated tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (Extended Release form) 25mg | 1 Tablet | M/s Ajanta Pharma Limited / M/s Glenmark Pharmaceuticals Ltd. | 9.86 |
10. | Amoxycillin Oral Suspension | Each 5ml of the reconstituted suspension contains: Amoxycillin Trihydrate eq. to Amoxycillin IP 125mg | 1 ML | M/s Theon Pharmaceuticals Limited / M/s Torrent Pharmaceuticals Limited | 0.80 |
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
11. | Amoxycillin Dispersible Tablet IP | Each uncoated dispersible tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 125mg | 1 Tablet | M/s Malik Lifesciences Pvt. Ltd. / M/s Torrent Pharmaceuticals Limited | 4.64 |
12. | Etamsylate & Tranexamic Acid Tablets | Each film coated tablet contains: Etamsylate BP 250mg, Tranexamic Acid IP 250mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Limited / M/s German Remedies Pharmaceuticals Private Limited | 17.26 |
13. | Atorvastatin Tablet IP | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 80mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Limited / M/s Mankind pharma Ltd. | 27.54 |
14. | Amoxycillin + Potassium Clavulanate Oral Suspenssion | Each 5ml after reconstituted suspension contains: Amoxycillin Trihydrate eq. to Amoxycillin IP 400mg Potassium Clavulanate Diluted eq. to Clavulanic Acid 57mg | 1 ML | M/s Torrent Pharmaceuticals Limited | 3.54 |
15. | Mefenamic Acid & Tranexamic Acid Tablets | Each film coated tablet contains: Mefenamic Acid IP 250mg Tranexamic Acid IP 500mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 25.07 |
16. | Povidone Iodine Gargle | Contains: Povidone-Iodine IP 2% w/v (Availabile Iodine 0.2 w/v) | 1 ML | M/s Nanz Medscience Pharma Pvt. Ltd. / M/s Glenmark Pharmaceuticals Ltd. | 1.72 |
17. | Azelnidipine + Telmisartan Tablet | Each film coated bi-layered tablet contains: Azelnidipine IP 8mg Telmisartan IP 80mg | 1 Tablet | M/s Synokem Pharmaceuticals Limited / M/s Mankind pharma Ltd. | 13.22 |
18. | Azelnidipine + Telmisartan Tablet | Each film coated bi-layered tablet contains: Azelnidipine IP 8mg Telmisartan IP 40mg | 1 Tablet | M/s Synokem Pharmaceuticals Limited / M/s Mankind pharma Ltd. | 11.02 |
19. | Nebivolol Hydrochloride + Telmisartan Tablet | Each uncoated bilayered tablet contains: Nebivolol Hydrochloride IP eq. to Nebivolol 5mg Telmisartan IP 40mg | 1 Tablet | M/s Windlas Biotech Private Limited / M/s | 12.59 |
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Mankind pharma Ltd. | |||||
20. | Vitamin D3 (Cholecalciferol) orally disintegrating stirps | Each orally disintegrating stirps contains: Vitamin D3 (Cholecalciferol) IP 60000 IU | Per Strip | M/s Zim Laboratories Ltd. / M/s Cadila Pharmaceuticals Ltd. | 20.16 |
21. | Torsemide + Spironolactone Tablet | Each Uncoated tablet contains: Torsemide IP 5mg Spironolactone IP 50mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s RPG Life Sciences Ltd. | 3.61 |
22. | Torsemide + Spironolactone Tablet | Each Uncoated tablet contains: Torsemide IP 10mg Spironolactone IP 50mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s RPG Life Sciences Ltd. | 5.07 |
23. | Pantoprazole & Domperidone Tablet | Each enteric coated tablet contains: Pantoprazole Sodium IP eq. to Pantoprazole 40mg Domperidone IP 10mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd. | 6.67 |
24. | Pantoprazole & Domperidone Tablet | Each enteric coated tablet contains: Pantoprazole Sodium IP eq. to Pantoprazole 20mg Domperidone IP 10mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd. | 5.72 |
25. | Telmisartan, Cilnidipine & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Eris Lifesciences Limited | 10.16 |
26. | Telmisartan, Cilnidipine & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Eris Lifesciences Limited | 12.41 |
27. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP 1000mg (as extended release form) Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Wockhardt Limited | 8.04 |
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
28. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP 500mg (as extended release form) Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Wockhardt Limited | 9.98 |
29. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP 1000mg (as extended release form) Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Wockhardt Limited | 11.53 |
30. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP/USP 500mg (As extended release) Dapagliflozin 5mg | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited | 6.65 |
31. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP/USP 1000mg (As extended release) Dapagliflozin 5mg | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited | 8.04 |
32. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP/USP 500mg (As extended release) Dapagliflozin 10mg | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited | 9.98 |
33. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP/USP 1000mg (As extended release) Dapagliflozin 10mg | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited | 11.53 |
34. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP/USP 500mg (as extended release form) Dapagliflozin 5mg | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. | 6.65 |
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
35. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP/USP 1000mg (as extended release form) Dapagliflozin 5mg | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. | 8.04 |
36. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP/USP 500mg (as extended release form) Dapagliflozin 10mg | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. | 9.98 |
37. | Dapagliflozin + Metformin Hydrochloride extended release Tablet | Each film coated tablet contains: Metformin Hydrochloride IP/USP 1000mg (as extended release form) Dapagliflozin 10mg | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. | 11.53 |
38. | Vildagliptin + Metformin Hydrochloride (SR) Tablet | Each uncoated bilayered tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 500mg (As sustained release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Alembic Pharmaceuticals Ltd. | 6.86 |
39. | Vildagliptin + Metformin Hydrochloride (SR) Tablet | Each uncoated bilayered tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 1000mg (As sustained release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Alembic Pharmaceuticals Ltd. | 7.51 |
40. | Alpha Lipoic Acid, Methylcobalamin, Selenium, Chromium Picolinate, Zinc Sulphate, Myo- Inositol & Folic Acid Capsule | Each soft gelatin capsule contains: Alpha Lipoic Acid USP 200mg Methylcobalamin IP 1500mcg, Selenium Dioxide Monohydrated USP eq. to Elemental Selenium 55mcg Chromium Picolinate USP 200mcg Zinc Sulphate IP 27.5mg Myo-Inositol BP 100mg Folic Acid IP 1.5mg | 1 Capsul e | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd. | 13.76 |
41. | Iron with Folic Acid & Cyanocobalamin Syrup | Each 5ml contains: Ferric Ammonium Citrate IP 110mg eq. to Elemental Iron 22.55mg Folic Acid IP 1.5mg | 1 ml | M/s Biogenetic Drugs Pvt. Ltd./ M/s Intas pharmaceuticals Ltd. | 0.16 |
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Cyanocobalamin IP 15mcg | |||||
42. |
Iron Vitamin B12 and Folic Acid Syrup | Each 5ml contains: Ferric Ammonium Citrate IP 110mg eq. to Elemental Iron 22.55mg Folic Acid IP 1.5mg Cyanocobalamin IP 15mcg |
1 ml | M/s East African (India) Overseas / M/s Intas pharmaceuticals Ltd. | 0.16 |
The notification further added;
(a) The manufacturer of above-mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
Also Read:NPPA Fixes Retail Price Of 41 Formulations; DetailsAlso Read:NPPA Fixes Retail Price Of 41 Formulations; Details
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd